Last Updated : February 4, 2019
Details
FilesProject Status:
Completed
Project Line:
Reference List
Project Sub Line:
Reference List
Project Number:
RA1009-000
Question
- What is the clinical effectiveness of switching from Herceptin or other biosimilars to Ogivri for patients with early breast cancer (EBC)?
- What is the clinical effectiveness of switching from Herceptin or other biosimilars to Ogivri for patients with metastatic breast cancer (MBC)?
- What is the clinical effectiveness of switching from Herceptin or other biosimilars to Ogivri for patients with metastatic gastric cancer (MGC)?
Files
Last Updated : February 4, 2019